RTU Research Outputs and Resources: Reasearch Staff

Information about Author

Name, Surname:

Raivis Žalubovskis

Department:

(32300) Ķīmijas un ķīmijas tehnoloģijas institūts

Scientific Degree:

Doktors

E-mail:

Raivis.Zalubovskis(at)rtu.lv

Publications

67 items found, displaying 31 to 40.

Development of Oxathiino[6,5-b]pyridine 2,2-Dioxide Derivatives as Selective Inhibitors of Tumor-Related Carbonic Anhydrases IX and XII
(2020)

Aiga Grandane, Alessio Nocentini, Ilona Domračeva, Raivis Žalubovskis, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

Benzoxepinones: A New Isoform-Selective Class of Tumor Associated Carbonic Anhydrase Inhibitors
(2020)

Aiga Grandane, Alessio Nocentini, Thomas Werner, Raivis Žalubovskis, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

Further Exploration of DVD-445 as a Lead Thioredoxin Reductase (TrxR) Inhibitor for Cancer Therapy: Optimization of Potency and Evaluation of Anticancer Potential
(2020)

Mirna Jovanovic, Daniil Zhukovsky, Ana Podolski-Renic, Raivis Žalubovskis, Dmitry Dar`in, Vladimir Sharoyko, Tatiana Tennikova, Milica Pešic, Mikhail Krasavin
Scientific article indexed in SCOPUS or WOS database

7-Acylamino-3H-1,2-benzoxathiepine 2,2-Dioxides as New Isoform-Selective Carbonic Anhydrase IX and XII Inhibitors
(2020)

Aleksandrs Pustenko, Alessio Nocentini, Anastasija Balašova, Mikhail Krasavin, Raivis Žalubovskis, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

Sulfocoumarins as Dual Inhibitors of Human Carbonic Anhydrase Isoforms IX/XII and of Human Thioredoxin Reductase
(2020)

Mikhail Krasavin, Raivis Žalubovskis, Aiga Grandane, Ilona Domračeva, Petr Zhmurov, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

The Antibiotic Furagin and Its Derivatives are Isoform-Selective Human Carbonic Anhydrase Inhibitors
(2020)

Aleksandrs Pustenko, Alessio Nocentini, Paola Gratteri, Alessandro Bonardi, Igor Vozny, Raivis Žalubovskis, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

Combining Carbonic Anhydrase and Thioredoxin Reductase Inhibitory Motifs within a Single Molecule Dramatically Increases Its Cytotoxicity
(2020)

Mikhail Krasavin, Tatiana Sharonova, Vladimir Sharoyko, Daniil Zhukovsky, Stanislav Kalinin, Raivis Žalubovskis, Tatiana Tennikova, Claudiu T. Supuran
Scientific article indexed in SCOPUS or WOS database

Novel Electrophilic Amides Amenable by the Ugi Reaction Perturb Thioredoxin System via Thioredoxin Reductase 1 (TrxR1) Inhibition: Identification of DVD-445 as a New Lead Compound for Anticancer Therapy
(2019)

M. Jovanovic, D. Zhukovsky, A. Podolski-Renic, I. Domračeva, Raivis Žalubovskis, M. Sencanski, S. Glišic, V. Sharoyko, T. Tennikova, D. Dar`in, M. Pešic, M. Krasavin
Scientific article indexed in SCOPUS or WOS database

Inhibitors of Selected Bacterial Metalloenzymes
(2019)

Raivis Žalubovskis, J.-Y. Winum
Scientific article indexed in SCOPUS or WOS database

Metalloenzymes as Therapeutic Targets
(2019)

B. Richichi, G.A. Spyroulias, J.-Y. Winum, Raivis Žalubovskis
Scientific article indexed in SCOPUS or WOS database

Information about Author

Publications

Development of Oxathiino[6,5-b]pyridine 2,2-Dioxide Derivatives as Selective Inhibitors of Tumor-Related Carbonic Anhydrases IX and XII
(2020)

Benzoxepinones: A New Isoform-Selective Class of Tumor Associated Carbonic Anhydrase Inhibitors
(2020)

Further Exploration of DVD-445 as a Lead Thioredoxin Reductase (TrxR) Inhibitor for Cancer Therapy: Optimization of Potency and Evaluation of Anticancer Potential
(2020)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-Dioxides as New Isoform-Selective Carbonic Anhydrase IX and XII Inhibitors
(2020)

Sulfocoumarins as Dual Inhibitors of Human Carbonic Anhydrase Isoforms IX/XII and of Human Thioredoxin Reductase
(2020)

The Antibiotic Furagin and Its Derivatives are Isoform-Selective Human Carbonic Anhydrase Inhibitors
(2020)

Combining Carbonic Anhydrase and Thioredoxin Reductase Inhibitory Motifs within a Single Molecule Dramatically Increases Its Cytotoxicity
(2020)

Novel Electrophilic Amides Amenable by the Ugi Reaction Perturb Thioredoxin System via Thioredoxin Reductase 1 (TrxR1) Inhibition: Identification of DVD-445 as a New Lead Compound for Anticancer Therapy
(2019)

Inhibitors of Selected Bacterial Metalloenzymes
(2019)

Metalloenzymes as Therapeutic Targets
(2019)

Supervised Dissertations

Synthesis of a New Type of Carbonic Anhydrases Inhibitors
(2020)

Synthesis of the Inhibitors of Carbonic Anhydrases and Thioredoxin Reductase as Potential Anticancer Agents
(2017)

Projects

Inovatīvu neiropātisko sāpju mazināšanas līdzekļu iegūšana
Citi

Information about Author

Publications

Development of Oxathiino[6,5-b]pyridine 2,2-Dioxide Derivatives as Selective Inhibitors of Tumor-Related Carbonic Anhydrases IX and XII (2020)

Benzoxepinones: A New Isoform-Selective Class of Tumor Associated Carbonic Anhydrase Inhibitors (2020)

Further Exploration of DVD-445 as a Lead Thioredoxin Reductase (TrxR) Inhibitor for Cancer Therapy: Optimization of Potency and Evaluation of Anticancer Potential (2020)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-Dioxides as New Isoform-Selective Carbonic Anhydrase IX and XII Inhibitors (2020)

Sulfocoumarins as Dual Inhibitors of Human Carbonic Anhydrase Isoforms IX/XII and of Human Thioredoxin Reductase (2020)

The Antibiotic Furagin and Its Derivatives are Isoform-Selective Human Carbonic Anhydrase Inhibitors (2020)

Combining Carbonic Anhydrase and Thioredoxin Reductase Inhibitory Motifs within a Single Molecule Dramatically Increases Its Cytotoxicity (2020)

Novel Electrophilic Amides Amenable by the Ugi Reaction Perturb Thioredoxin System via Thioredoxin Reductase 1 (TrxR1) Inhibition: Identification of DVD-445 as a New Lead Compound for Anticancer Therapy (2019)

Inhibitors of Selected Bacterial Metalloenzymes (2019)

Metalloenzymes as Therapeutic Targets (2019)

Supervised Dissertations

Synthesis of a New Type of Carbonic Anhydrases Inhibitors (2020)

Synthesis of the Inhibitors of Carbonic Anhydrases and Thioredoxin Reductase as Potential Anticancer Agents (2017)

Projects

Inovatīvu neiropātisko sāpju mazināšanas līdzekļu iegūšana Citi

Development of Oxathiino[6,5-b]pyridine 2,2-Dioxide Derivatives as Selective Inhibitors of Tumor-Related Carbonic Anhydrases IX and XII
(2020)

Benzoxepinones: A New Isoform-Selective Class of Tumor Associated Carbonic Anhydrase Inhibitors
(2020)

Further Exploration of DVD-445 as a Lead Thioredoxin Reductase (TrxR) Inhibitor for Cancer Therapy: Optimization of Potency and Evaluation of Anticancer Potential
(2020)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-Dioxides as New Isoform-Selective Carbonic Anhydrase IX and XII Inhibitors
(2020)

Sulfocoumarins as Dual Inhibitors of Human Carbonic Anhydrase Isoforms IX/XII and of Human Thioredoxin Reductase
(2020)

The Antibiotic Furagin and Its Derivatives are Isoform-Selective Human Carbonic Anhydrase Inhibitors
(2020)

Combining Carbonic Anhydrase and Thioredoxin Reductase Inhibitory Motifs within a Single Molecule Dramatically Increases Its Cytotoxicity
(2020)

Novel Electrophilic Amides Amenable by the Ugi Reaction Perturb Thioredoxin System via Thioredoxin Reductase 1 (TrxR1) Inhibition: Identification of DVD-445 as a New Lead Compound for Anticancer Therapy
(2019)

Inhibitors of Selected Bacterial Metalloenzymes
(2019)

Metalloenzymes as Therapeutic Targets
(2019)

Synthesis of a New Type of Carbonic Anhydrases Inhibitors
(2020)

Synthesis of the Inhibitors of Carbonic Anhydrases and Thioredoxin Reductase as Potential Anticancer Agents
(2017)

Inovatīvu neiropātisko sāpju mazināšanas līdzekļu iegūšana
Citi